Advertisement
ALVO vs GLCR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a Hold and GLCR is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALVO’s FA Score shows that 1 FA rating(s) are green while.
- ALVO’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALVO’s TA Score shows that 6 TA indicator(s) are bullish.
- ALVO’s TA Score: 6 bullish, 4 bearish.
Price Growth
ALVO (@Pharmaceuticals: Generic) experienced а +9.25% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.60%. For the same industry, the average monthly price growth was +6.53%, and the average quarterly price growth was +30.86%.
Reported Earning Dates
ALVO is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (+1.60% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
| ALVO | GLCR | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 75% | 3 days ago 73% |
| Stochastic ODDS (%) | 3 days ago 70% | 3 days ago 73% |
| Momentum ODDS (%) | 3 days ago 68% | 3 days ago 76% |
| MACD ODDS (%) | 3 days ago 64% | 3 days ago 70% |
| TrendWeek ODDS (%) | 3 days ago 63% | 3 days ago 74% |
| TrendMonth ODDS (%) | 3 days ago 59% | 3 days ago 68% |
| Advances ODDS (%) | 3 days ago 70% | 12 days ago 72% |
| Declines ODDS (%) | about 1 month ago 76% | 6 days ago 70% |
| BollingerBands ODDS (%) | 3 days ago 60% | 3 days ago 67% |
| Aroon ODDS (%) | 3 days ago 63% | 3 days ago 57% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FLEU | 36.89 | 0.15 | +0.40% |
| Franklin FTSE Eurozone ETF | |||
| TSEP | 26.60 | N/A | N/A |
| FT Vest Emerging Mkts Buffr ETF - Sep | |||
| QLTA | 46.40 | -0.04 | -0.10% |
| iShares Aaa - A Rated Corporate Bond ETF | |||
| JIII | 49.64 | -0.08 | -0.16% |
| Janus Henderson Income ETF | |||
| AMZU | 37.46 | -0.49 | -1.29% |
| Direxion Daily AMZN Bull 2X Shares | |||
ALVO and
Correlation & Price change
A.I.dvisor tells us that ALVO and CRON have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and CRON's prices will move in lockstep.
| Ticker / NAME | Correlation To ALVO | 1D Price Change % | ||
|---|---|---|---|---|
| ALVO | 100% | +3.75% | ||
| CRON - ALVO | 24% Poorly correlated | +2.80% | ||
| EBS - ALVO | 24% Poorly correlated | +5.39% | ||
| PAHC - ALVO | 22% Poorly correlated | +3.24% | ||
| ACB - ALVO | 22% Poorly correlated | +3.41% | ||
| LFCR - ALVO | 21% Poorly correlated | +0.44% | ||
More | ||||
GLCR and
Correlation & Price change
A.I.dvisor indicates that over the last year, GLCR has been loosely correlated with OCS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if GLCR jumps, then OCS could also see price increases.
| Ticker / NAME | Correlation To GLCR | 1D Price Change % | ||
|---|---|---|---|---|
| GLCR | 100% | +1.41% | ||
| OCS - GLCR | 40% Loosely correlated | -0.42% | ||
| ALVO - GLCR | 34% Loosely correlated | +3.75% | ||
| JBTM - GLCR | 18% Poorly correlated | +0.60% |